A detailed history of Factorial Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Factorial Partners, LLC holds 36,500 shares of BMY stock, worth $2.1 Million. This represents 1.21% of its overall portfolio holdings.

Number of Shares
36,500
Previous 35,000 4.29%
Holding current value
$2.1 Million
Previous $1.45 Million 29.94%
% of portfolio
1.21%
Previous 0.99%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$39.66 - $51.75 $59,489 - $77,625
1,500 Added 4.29%
36,500 $1.89 Million
Q2 2024

Aug 07, 2024

SELL
$40.25 - $52.99 $241,500 - $317,940
-6,000 Reduced 14.63%
35,000 $1.45 Million
Q1 2024

May 14, 2024

SELL
$47.98 - $54.4 $47,980 - $54,400
-1,000 Reduced 2.38%
41,000 $2.22 Million
Q4 2023

Feb 13, 2024

SELL
$48.48 - $57.85 $392,688 - $468,585
-8,100 Reduced 16.17%
42,000 $2.16 Million
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $468,909 - $524,313
-8,100 Reduced 13.92%
50,100 $2.91 Million
Q2 2023

Aug 02, 2023

BUY
$63.71 - $70.74 $407,744 - $452,735
6,400 Added 12.36%
58,200 $3.72 Million
Q1 2023

May 03, 2023

BUY
$65.71 - $74.53 $492,824 - $558,975
7,500 Added 16.93%
51,800 $3.59 Million
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $1.4 Million - $1.65 Million
20,400 Added 85.36%
44,300 $3.19 Million
Q3 2022

Nov 04, 2022

SELL
$0.13 - $76.84 $247 - $145,996
-1,900 Reduced 7.36%
23,900 $1.7 Million
Q2 2022

Aug 03, 2022

SELL
$72.62 - $79.98 $987,632 - $1.09 Million
-13,600 Reduced 34.52%
25,800 $1.99 Million
Q1 2022

May 03, 2022

SELL
$61.48 - $73.72 $2.02 Million - $2.43 Million
-32,900 Reduced 45.5%
39,400 $2.88 Million
Q4 2021

Feb 09, 2022

BUY
$53.63 - $62.52 $321,780 - $375,120
6,000 Added 9.05%
72,300 $4.51 Million
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $372,771 - $436,653
6,300 Added 10.5%
66,300 $3.92 Million
Q1 2021

May 21, 2021

SELL
$59.34 - $66.74 $221 Million - $249 Million
-3,727,800 Reduced 98.42%
60,000 $3.79 Million
Q1 2021

May 17, 2021

BUY
$59.34 - $66.74 $223 Million - $250 Million
3,750,600 Added 10082.26%
3,787,800 $60 Million
Q4 2020

Feb 16, 2021

BUY
$57.74 - $65.43 $320,457 - $363,136
5,550 Added 17.54%
37,200 $2.31 Billion
Q3 2020

Nov 12, 2020

BUY
$57.43 - $63.64 $14,357 - $15,910
250 Added 0.8%
31,650 $1.91 Billion
Q2 2020

Aug 13, 2020

BUY
$54.82 - $64.09 $1.11 Million - $1.3 Million
20,300 Added 182.88%
31,400 $1.85 Billion
Q1 2020

May 15, 2020

SELL
$46.4 - $67.43 $176,320 - $256,234
-3,800 Reduced 25.5%
11,100 $619 Million
Q4 2019

Feb 11, 2020

BUY
$49.21 - $64.19 $733,229 - $956,431
14,900 New
14,900 $956 Million
Q3 2019

Nov 12, 2019

SELL
$42.77 - $50.71 $564,564 - $669,372
-13,200 Closed
0 $0
Q2 2019

Aug 15, 2019

SELL
$44.62 - $49.34 $401,580 - $444,060
-9,000 Reduced 40.54%
13,200 $599 Million
Q1 2019

May 10, 2019

SELL
$45.12 - $53.8 $1.96 Million - $2.34 Million
-43,500 Reduced 66.21%
22,200 $1.06 Billion
Q4 2018

Feb 14, 2019

BUY
$48.76 - $63.23 $643,632 - $834,636
13,200 Added 25.14%
65,700 $3.42 Billion
Q3 2018

Nov 08, 2018

SELL
$55.19 - $62.25 $165,570 - $186,750
-3,000 Reduced 5.41%
52,500 $3.26 Billion
Q2 2018

Aug 01, 2018

BUY
$50.53 - $62.98 $2.8 Million - $3.5 Million
55,500 New
55,500 $3.07 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Factorial Partners, LLC Portfolio

Follow Factorial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Factorial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Factorial Partners, LLC with notifications on news.